Mentor Capital, Inc. is a private equity firm based in Ramona, California, that specializes in investments within the medical and social use cannabis sectors. Founded in 1985, Mentor Capital focuses on providing passive equity funding and liquidity to smaller cannabis companies, enabling them to access public markets through shelf IPOs and other investment avenues. The firm typically invests in companies with earnings and sales exceeding $40 million, taking significant stakes while allowing founders to maintain operational control. Mentor Capital aims to facilitate the application of cannabis for various medical conditions, including cancer-related issues, seizures, and chronic pain. The company has transitioned from its original focus on cancer investments to concentrate on the burgeoning cannabis market, seeking long-term cooperative financing solutions that offer founders more cash while retaining a smaller equity share. Through its unique capital structure, Mentor Capital strives to enhance shareholder value and encourage private cannabis firms to engage in partnerships that support their growth.
eShiksa is a developer of an education management portal that streamlines the operational processes of educational institutions. The platform features Shiksa Pay, a flexible fee management system that allows institutes to oversee various categories of fees efficiently. Students and parents can easily make online payments through their accounts or cards, providing convenience from any location. The mobile app enhances this service by enabling payments on smartphones and tablets. eShiksa's portal offers a comprehensive view of academic reports and facilitates the management, analysis, and reporting of extensive data, thereby saving time and reducing redundancy in data entry. Furthermore, it equips administrators with critical financial insights for effective planning and forecasting.
G Farma Labs
Venture Round in 2018
G Farma Labs supplies cannabis related products. That products include G Stik, G Drinks, Liquid Gold Vape Oil, chocolates, and cannabis pre-rolls. They also offer sprinkled with kief, and liquid goal CO2 extracted cannabis oil for the smoke.
GW Pharmaceuticals
Post in 2017
GW Pharmaceuticals is a biopharmaceutical company based in Cambridge, United Kingdom, that specializes in the discovery, development, and commercialization of innovative therapeutics derived from its proprietary cannabinoid platform. Its primary product, Epidiolex, is an oral solution used to treat seizures associated with Lennox-Gastaut syndrome and Dravet syndrome in patients aged one year and older, and it is also under review for the treatment of tuberous sclerosis complex. In Europe, the product is marketed as Epidyolex. The company also offers Sativex, which is used for managing spasticity due to multiple sclerosis, and is advancing various cannabinoid product candidates aimed at treating conditions such as schizophrenia, autism spectrum disorder, and neonatal hypoxic ischemic encephalopathy. GW Pharmaceuticals operates primarily in Europe, the United Kingdom, and the United States, and has been established since 1998.
Bhang
Venture Round in 2014
Bhang Inc. specializes in the production and distribution of cannabis-infused products on a global scale. The company offers a diverse portfolio that includes more than 100 products, featuring gourmet chocolates, CBD gummies, capsules, e-liquids, tinctures, and pre-rolls, among others. Bhang focuses on utilizing high-quality ingredients to create medicated edibles that emphasize both quality and effectiveness. With a presence in key markets such as Canada and the United States, Bhang aims to cater to a wide range of consumer preferences within the evolving cannabis industry.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.